IAPAM Medical Aesthetics, Botox, Medical Weight Loss Information - Page 3

Celebrating 20 Years of Training in Botox®, Aesthetic Medicine
and Medical Weight Management

Days

Hours

Minutes

Save 25% on Hands-on Botox® Training

All 2026 dates on sale. Register before December 31!

Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification

Save 25% off all 2026 Botox Training Dates!

Sale ends in:

Days

Hours

Minutes

GLP-1 Round-Up July Edition

GLP‑1 Weight Loss Providers Roundup: July 2025 Updates for Clinical Practice

For GLP‑1 weight loss providers, the latest research, reimbursement changes, and pipeline drugs are redefining how you support patients. This roundup offers concise guidance on preserving lean mass, improving adherence, navigating coverage, and preparing for next‑generation therapies.

IAPAM - The Latest GLP-1 Trends

GLP-1 Trends June 2025: Why 50% of Patients Quit Early

GLP-1 trends in June 2025 are redefining obesity treatment—but real-world data reveals more than half of patients quit within a year. This article explores why, what’s coming next, and how providers can adapt to a rapidly changing landscape.

How to Start Gauging Botox® Patient Satisfaction (and Use Feedback to Grow Your Practice)

How to Start Gauging Botox® Patient Satisfaction (and Use Feedback to Grow Your Practice)

Botox patient satisfaction now defines success in modern aesthetic practice. This guide shows new injectors how to capture feedback, build trust, and grow their business.

Preserve Muscle During Weight Loss? Regeneron’s COURAGE Trial Suggests a New Path with Antibody Therapy

Preserve Muscle During Weight Loss? Regeneron’s COURAGE Trial Suggests a New Path with Antibody Therapy

Semaglutide is effective for weight loss—but nearly 35% of that loss can be lean muscle. The COURAGE trial from Regeneron explores a novel antibody co-therapy that may protect muscle and improve fat loss outcomes, setting a new bar for obesity treatment.